NFKB1 and urinary bladder carcinoma: In summary, we found URGCP/URG4 was high expression in bladder cancer cells and tissues, it promoted the resistance to cisplatin-induced cell apoptosis in bladder cancer, mechanism analysis found it activated NF-κB pathway to inhibit apoptosis.